Licia Tomei

9.7k total citations · 1 hit paper
92 papers, 7.9k citations indexed

About

Licia Tomei is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Licia Tomei has authored 92 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 32 papers in Hepatology and 20 papers in Epidemiology. Recurrent topics in Licia Tomei's work include Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (16 papers) and Cell death mechanisms and regulation (12 papers). Licia Tomei is often cited by papers focused on Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (16 papers) and Cell death mechanisms and regulation (12 papers). Licia Tomei collaborates with scholars based in Italy, United States and Germany. Licia Tomei's co-authors include Raffaele De Francesco, Frederick O. Cope, Samuil R. Umansky, Cristina Maria Failla, Sven‐Erik Behrens, Michael Kiefer, Philip J. Barr, F.A. Rey, Stéphane Bressanelli and Sergio Altamura and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Licia Tomei

91 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus.

1996 569 citations Sven‐Erik Behrens, Licia Tomei et al. profile →

Peers

Countries citing papers authored by Licia Tomei

Since Specialization

Citations

This map shows the geographic impact of Licia Tomei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licia Tomei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licia Tomei more than expected).

Fields of papers citing papers by Licia Tomei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Licia Tomei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licia Tomei. The network helps show where Licia Tomei may publish in the future.

Co-authorship network of co-authors of Licia Tomei

This figure shows the co-authorship network connecting the top 25 collaborators of Licia Tomei. A scholar is included among the top collaborators of Licia Tomei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Licia Tomei. Licia Tomei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington’s disease pathogenesis 2022 ·PLoS Genetics ·(unknown), Gang Li, Xin Ye, Dongsheng Chen, Zhihua Chen, Zhen Xu, Daniele Moretti, (unknown), Alessandra Ceccacci, Licia Tomei, (unknown), (unknown), (unknown), (unknown), Erin Furr Stimming, George McAllister, Deanna M. Marchionini, Sheng Zhang	9
2	NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model 2020 ·Free Radical Biology and Medicine ·Daniele Moretti, (unknown), Mauro Cerretani, (unknown), Antonino Missineo, (unknown), (unknown), Steven J. Harper, (unknown), Robert E. Pacifici, Licia Tomei, Larry Park, Alberto Bresciani	39
3	Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library 2018 ·Scientific Reports ·Anna Demartis, Armin Lahm, Licia Tomei, Elisa Beghetto, (unknown), Federica Orvieto, (unknown), Paul E. Carrington, (unknown), Brian E. Hawes, Elisabetta Bianchi, Anandan Palani, Antonello Pessi	9
4	Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1) 2017 ·Archives of Biochemistry and Biophysics ·Alberto Bresciani, Antonino Missineo, Mariana Gallo, Mauro Cerretani, (unknown), Licia Tomei, Daniel O. Cicero, Sergio Altamura, Alessia Santoprete, Raffaele Ingenito, Elisabetta Bianchi, Robert E. Pacifici, Celia Dominguez, Ignacio Muñoz-Sanjuán, Steven J. Harper, Leticia Toledo‐Sherman, Larry C. Park	42
5	High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting 2015 ·PLoS ONE ·Christopher G. Ullman, (unknown), Arkadiusz Oleksy, (unknown), Licia Tomei, Anna Demartis, Chiara Nardi, Sonia Sambucini, Antonino Missineo, Karen Alt, Christoph E. Hagemeyer, (unknown), (unknown), Roland Weís, Kurt R. Gehlsen	13
6	2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp 2009 ·Bioorganic & Medicinal Chemistry Letters ·Barbara Pacini, (unknown), (unknown), Uwe Koch, Giovanni Migliaccio, Frank Narjes, Laura Pacini, Licia Tomei, Steven J. Harper	5
7	Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3 2007 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Eleonora Forte, Laura Orsatti, Fabio Talamo, Gaetano Barbato, Raffaele De Francesco, Licia Tomei	61
8	Transrenal DNA testing: progress and perspectives 2006 ·Expert Review of Molecular Diagnostics ·Samuil R. Umansky, Licia Tomei	50
9	Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site 2005 ·Journal of Biological Chemistry ·Stefania Di Marco, Cinzia Volpari, Licia Tomei, Sergio Altamura, (unknown), Frank Narjes, Uwe Koch, Michael Rowley, Raffaele De Francesco, Giovanni Migliaccio, Andrea Carfı́	135
10	Rational design and functional expression of a constitutively active single-chain NS4A–NS3 proteinase 1998 ·PubMed ·Alessandra Pasquo, Maria Chiara Nardi, Nazzareno Dimasi, Licia Tomei, Christian Steinkühler, Paola Delmastro, Anna Tramontano, Raffaele De Francesco	11
11	AGING AND APOPTOSIS CONTROL 1998 ·Neurologic Clinics ·Licia Tomei, Samuil R. Umansky	12
12	Apoptosis in the Heart 1997 ·Advances in pharmacology ·Samuil R. Umansky, Licia Tomei	38
13	ANTIAPOPTOTIC COMPOUND TO ENHANCE HYPOTHERMIC LIVER PRESERVATION1 1997 ·Transplantation ·Guanghan Wu, Licia Tomei, Ian Bathurst, (unknown), (unknown), Charles J. Issel, (unknown), Robert K. Salley, Sufan Chien	17
14	Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion 1997 ·Cell Death and Differentiation ·Samuil R. Umansky, John P. Shapiro, (unknown), (unknown), Ian Bathurst, Licia Tomei	38
15	Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression 1997 ·Journal of Biological Chemistry ·Natalya Ossina, Angela Cannas, (unknown), Paul Fitzpatrick, (unknown), James R. Gilbert, Eugene Shekhtman, Licia Tomei, Samuil R. Umansky, Michael Kiefer	244
16	[4] RNA-dependent RNA polymerase of hepatitis C virus 1996 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Raffaele De Francesco, Sven‐Erik Behrens, Licia Tomei, Sergio Altamura, Josef Jiricny	68
17	Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak 1995 ·Nature ·Michael Kiefer, Matthew J. Brauer, (unknown), Jason Wu, Samuil R. Umansky, Licia Tomei, Philip J. Barr	446
18	Apoptosis and Its Role in Human Disease 1994 ·Bio/Technology ·Philip J. Barr, Licia Tomei	193
19	Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variants 1989 ·Human Genetics ·Licia Tomei, Chin B. Eap, Pierre Baumann, Luciana Dente	35
20	Restoration of growth control in malignantly transformed mouse fibroblasts grown in a chemically defined medium. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Licia Tomei, John S. Bertram	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact